This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaper, F. Articles by Giaccia, A. J. Search for Related Content PubMed PubMed Citation Articles by Kaper, F. Articles by Giaccia, A. J.

Mutations in the PI3K/PTEN/TSC2 Pathway Contribute to Mammalian Target of Rapamycin Activity and Increased Translation under Hypoxic Conditions

¹ Department of Radiation Oncology, Stanford University, Stanford, California and ² Department of Obstetrics and Gynecology, University of Leipzig, Leipzig, Germany

Requests for reprints: Amato J. Giaccia, Radiation Biology Division, Department of Radiation Oncology, Stanford University, Center for Clinical Sciences Research, South Room 1255, 269 Campus Drive, Stanford, CA 94305-5152. Phone: 650-723-7366; Fax: 650-723-7382; E-mail: giaccia{at}stanford.edu.

Decreased oxygen causes a rapid inhibition of mRNA translation. An important regulatory mechanism of translational repression under hypoxic conditions involves inhibition of the mammalian target of rapamycin (mTOR). mTOR is a target of the phosphatase and tensin homologue detected on chromosome 10 (PTEN)/phosphatidylinositol 3-kinase/AKT/TSC2 pathway, a pathway that is frequently mutated in human cancers. Although hypoxia has been shown to inhibit mTOR activity, we show here that the hypoxia-induced inhibition of mTOR activity is attenuated in cells lacking TSC2 or PTEN, resulting in a higher translation rate even under hypoxic conditions. Comparison of mTOR inhibition by hypoxia alone or in combination with rapamycin showed that prolonged exposure to hypoxia was required to fully inhibit mTOR activity even in wild-type cells. Increased mTOR activity and protein synthesis did not translate into enhanced cell proliferation rates. However, lack of TSC2 resulted in a survival advantage when cells were exposed to hypoxia. Protection against hypoxia-induced cell death due to TSC2 deficiency is rapamycin-resistant, suggesting that TSC2 affects an apoptotic pathway. Tumors derived from TSC2 wild-type cells exhibited a growth delay compared with TSC2-deficient tumors, indicating that enhanced mTOR activity is advantageous in the initial phase of tumor growth. Therefore, failure to inhibit mTOR under oxygen-limiting conditions can be affected by upstream activating mutations and increases the survival and growth of hypoxic tumor cells. (Cancer Res 2006; 66(3): 1561-9)

This article has been cited by other articles:

				L. ANNOVAZZI, M. MELLAI, V. CALDERA, G. VALENTE, L. TESSITORE, and D. SCHIFFER mTOR, S6 and AKT Expression in Relation to Proliferation and Apoptosis/Autophagy in Glioma Anticancer Res, August 1, 2009; 29(8): 3087 - 3094. [Abstract] [Full Text] [PDF]

				H. U. Park, S. Suy, M. Danner, V. Dailey, Y. Zhang, H. Li, D. R. Hyduke, B. T. Collins, G. Gagnon, B. Kallakury, et al. AMP-activated protein kinase promotes human prostate cancer cell growth and survival Mol. Cancer Ther., April 1, 2009; 8(4): 733 - 741. [Abstract] [Full Text] [PDF]

				J. Marsh, P. Mukherjee, and T. N. Seyfried Akt-Dependent Proapoptotic Effects of Dietary Restriction on Late-Stage Management of a Phosphatase and Tensin Homologue/Tuberous Sclerosis Complex 2-Deficient Mouse Astrocytoma Clin. Cancer Res., December 1, 2008; 14(23): 7751 - 7762. [Abstract] [Full Text] [PDF]

				S.-J. Lee, R. Feldman, and P. H. O'Farrell An RNA Interference Screen Identifies a Novel Regulator of Target of Rapamycin That Mediates Hypoxia Suppression of Translation in Drosophila S2 Cells Mol. Biol. Cell, October 1, 2008; 19(10): 4051 - 4061. [Abstract] [Full Text] [PDF]

				B. Bilanges, R. Argonza-Barrett, M. Kolesnichenko, C. Skinner, M. Nair, M. Chen, and D. Stokoe Tuberous Sclerosis Complex Proteins 1 and 2 Control Serum-Dependent Translation in a TOP-Dependent and -Independent Manner Mol. Cell. Biol., August 15, 2007; 27(16): 5746 - 5764. [Abstract] [Full Text] [PDF]

				R. T. Kurmasheva, F. C. Harwood, and P. J. Houghton Differential regulation of vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumors Mol. Cancer Ther., May 1, 2007; 6(5): 1620 - 1628. [Abstract] [Full Text] [PDF]

				N. Pore, Z. Jiang, H.-K. Shu, E. Bernhard, G. D. Kao, and A. Maity Akt1 Activation Can Augment Hypoxia-Inducible Factor-1{alpha} Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin-Independent Pathway Mol. Cancer Res., July 1, 2006; 4(7): 471 - 479. [Abstract] [Full Text] [PDF]

				C. Koumenis and B. G. Wouters "Translating" Tumor Hypoxia: Unfolded Protein Response (UPR)-Dependent and UPR-Independent Pathways Mol. Cancer Res., July 1, 2006; 4(7): 423 - 436. [Abstract] [Full Text] [PDF]